Binding of liposomes to human bladder tumor epithelial cell lines: implications for an intravesical drug delivery system for the treatment of bladder cancerJOHNSON, J. W; RAJIV NAYAR; KILLION, J. D et al.Cancer drug delivery. 1989, Vol 5, Num 4, pp 147-155, issn 0732-9482Article

Cellular viability in human tumor micro-organ cultures: in situ quantitation by image processingROTMAN, B; CAMPANELLA, M. W; OLDMIXON, E. H et al.Cancer drug delivery. 1989, Vol 5, Num 4, pp 185-192, issn 0732-9482Article

Targeted drug delivery: a two-compartment growth inhibition assay demonstrates that fluorodeoxyuridine and fluorodeoxyuridine monophosphate are liposome-independent drugsHEATH, T. D; BROWN, C. S.Cancer drug delivery. 1989, Vol 5, Num 4, pp 179-184, issn 0732-9482Article

Utility of topical formulations of morphine hydrochloride containing azone and N-Méthyl-2-pyrrolidoneSUGIBAYASHI, K; SAKANOUE, C; MORIMOTO, Y et al.Cancer drug delivery. 1989, Vol 5, Num 3, pp 119-128, issn 0732-9482Article

Microparticulate drug delivery systems as an adjunct to cancer treatmentKERR, D. J.Cancer drug delivery. 1987, Vol 4, Num 1, pp 55-61, issn 0732-9482Article

Phase 2 trial of streptozotocin by continuous infusion for metastatic colorectal carcinomaCLAMON, G; RIGGS, C; STEGINK, L et al.Cancer drug delivery. 1987, Vol 4, Num 1, pp 43-46, issn 0732-9482Article

Treatment of astrocytoma with a 5-day cisplatin infusionGRUNBERG, S. M; BERTRAM, J. H; MCDERMED, J. E et al.Cancer drug delivery. 1987, Vol 4, Num 1, pp 47-53, issn 0732-9482Article

Biological activities of 5-fluorouracil and its prodrug 5'-deoxy-5-fluorouridine in ratsAU, J. L.-S; RUSTUM, Y. M; SLOCUM, H. K et al.Cancer drug delivery. 1987, Vol 4, Num 3, pp 137-144, issn 0732-9482Article

Kinetics of methotrexate and its metabolites in red blood cellsLENA, N; IMBERT, A. M; BRUNET, P et al.Cancer drug delivery. 1987, Vol 4, Num 2, pp 119-127, issn 0732-9482Article

Management of infectious complications of intraventricular reservoirs in cancer patients: low incidence and successful treatment without reservoir removalDINNDORF, P. A; BLEYER, W. A.Cancer drug delivery. 1987, Vol 4, Num 2, pp 105-117, issn 0732-9482Article

Resistance of V79 multicell spheroids to mitoxantrone: drug uptake and cytotoxicityBICHAY, T. J; INCH, W. R.Cancer drug delivery. 1987, Vol 4, Num 4, pp 210-211, issn 0732-9482Article

131-I coupled to monoclonal antibodies as therapeutic agents for neuroectodermally derived tumors: fact or fiction?KEMSHEAD, J. T; JONES, D. H; LASHFORD, L et al.Cancer drug delivery. 1986, Vol 3, Num 1, pp 25-43, issn 0732-9482Article

Drug sensitivity testing of carcinoma of the gallbladder and biliary tree in a human tumor cloning assayHARRIS, G. J; VON HOFF, D. D.Cancer drug delivery. 1986, Vol 3, Num 3, pp 197-204, issn 0732-9482Article

Low dose ara-C administered by continuous subcutaneous infusion: a pharmacologic evaluationSPRIGGS, D. R; SOKAL, J. E; GRIFFIN, J et al.Cancer drug delivery. 1986, Vol 3, Num 3, pp 211-216, issn 0732-9482Article

Reversal of intrinsic resistance to adriamycin in normal cells by verapamilLAMPIDIS, T. J; KRISHAN, A; PLANAS, L et al.Cancer drug delivery. 1986, Vol 3, Num 4, pp 251-259, issn 0732-9482Article

Selective killing of normal and neoplastic human B cells with anti-CD19- and anti-CD22-ricin A chain immunotoxinsMAY, R. D; VITETTA, E. S; MOLDENHAUER, G et al.Cancer drug delivery. 1986, Vol 3, Num 4, pp 261-272, issn 0732-9482Article

The role of drug sequence in therapeutic selectivity of the combination of 5-fluorouracil and cis-platinPALMERI, S; TRAVE, F; RUSSELLO, O et al.Cancer drug delivery. 1989, Vol 5, Num 4, pp 169-177, issn 0732-9482Article

Distribution of a conjugate of 9-β-D-arabinofuranosyladenine 5'-monophosphate (ara-AMP) with lactosaminated albumin in parenchymal and sinusoidal cells of rat liverFIUME, L; MATTIOLI, A; SPINOSA, G et al.Cancer drug delivery. 1987, Vol 4, Num 1, pp 11-16, issn 0732-9482Article

Experimental comparison between hepatic artery infusion and occlusion-infusion of adriamycinWRIGHT, K. C; WALLACE, S; BENJAMIN, R. S et al.Cancer drug delivery. 1987, Vol 4, Num 1, pp 33-41, issn 0732-9482Article

Restoration of drug sensitivity by nitroxazepine hydrochloride in P388 murine leukemia cells resistant to adriamycinCHITNIS, M. P; PRADHAN, S. G; STAYAMOORTHY, K et al.Cancer drug delivery. 1987, Vol 4, Num 1, pp 1-9, issn 0732-9482Article

Conjugates of ara-AMP with lactosaminated albumin: a study on their immunogenicity in mouse and ratFIUME, L; BUSI, C; PRETI, P et al.Cancer drug delivery. 1987, Vol 4, Num 3, pp 145-150, issn 0732-9482Article

Levels of dihydrofolate reductase in livers of birds, animals, primates, and manWHITEHEAD, V. M; KAMEN, B. A; BEAULIEU, D et al.Cancer drug delivery. 1987, Vol 4, Num 3, pp 185-189, issn 0732-9482Article

Direct effects of the hypoxic cell sensitizer misonidazole on colony formation in a human tumor cloning assaySCHEITHAUER, W; VON HOFF, D. D; FORSETH, B et al.Cancer drug delivery. 1986, Vol 3, Num 1, pp 15-24, issn 0732-9482Article

Totally implantable catheters for cancer chemotherapy: French experience on 325 casesCHAMPAULT, G.Cancer drug delivery. 1986, Vol 3, Num 2, pp 131-137, issn 0732-9482Article

CIS Platine (CDDP) in continuous intravenous ambulatory infusion: a new method of administrationBENAHMED, M; RENAUX, J; SPIELMAN, M et al.Cancer drug delivery. 1986, Vol 3, Num 3, pp 183-188, issn 0732-9482Article